IDWEEK 2017 – Pediatric Infectious Diseases

Age-appropriate doses of IV peramivir were compared to five days of oral oseltamivir in patients aged 0-17 years.

Whereas epidemiological risk factors for CDI among adults are well known, data is limited for children.

Appropriate diagnosis was defined as confirmed UTI which included: pyuria, a positive urine culture, and lower urinary tract symptoms.

The composition of the developing gut microbiome is thought to have crucial roles in maturation of the immune system.

Differences in total daily dose, AUC24, and AUC24/MIC were the primary endpoints of the study. Secondary endpoints assessed adverse events.

Data was compiled from electronic records for patients aged 3 months to 18 years who were diagnosed with CAP between 2009 and 2013.